Cyramza Overdosage

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Overdosage

There is no data on overdose in humans. Ramucirumab (Cyramza) has been administered in a phase 1 study up to 10 mg/Kg every two weeks without reaching a maximum tolerated dose. In case of overdose, supportive therapy should be used.

ramucirumab

Manufacturer:

Eli Lilly

Distributor:

Zuellig